All News

Allogeneic

Revolutionizing Regenerative Medicine: Exploring the Promise and Challenges of Allogeneic Therapies
28 November 2023
Revolutionizing Regenerative Medicine: Exploring the Promise and Challenges of Allogeneic Therapies
David Sourdive joins us in
Beam Therapeutics Announced First Patient Dosed in Phase I/II Trial in Relapsed, Refractory T-ALL/T-LL
6 September 2023
Beam Therapeutics Announced First Patient Dosed in Phase I/II Trial in Relapsed, Refractory T-ALL/T-LL
Beam Therapeutics Announced First Patient
Cellares Raises $255M Series C to Launch First Integrated Development and Manufacturing Organization
24 August 2023
Cellares Raises $255M Series C to Launch First Integrated Development and Manufacturing Organization
Cellares has secured $255 million
Precision BioSciences Completes Strategic $227M Transaction with Imugene for CAR-T Therapy
17 August 2023
Precision BioSciences Completes Strategic $227M Transaction with Imugene for CAR-T Therapy
Precision BioSciences Completes Strategic Transaction
POPULAR NEWS ITEMS
Image
4 December 2023

20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry

Image
6 December 2023

Oxford Biomedica Acquires ABL Europe from Institut Mérieux

Image
5 December 2023

Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome

Kyverna’s Series B Financing Round Extends to $145M
3 August 2023
Kyverna’s Series B Financing Round Extends to $145M
Kyverna Therapeutics has oversubscribed its
First Type 1 Diabetes Cell Therapy Approved by the FDA
28 July 2023
First Type 1 Diabetes Cell Therapy Approved by the FDA
The FDA has approved the
First Allogeneic Stem Cell Transplant Therapy Approved by the FDA
19 April 2023
First Allogeneic Stem Cell Transplant Therapy Approved by the FDA
Cell therapy pioneer Gamida Cell
Adaptimmune and TCR2 Collaborate to Develop Cell Therapies for Solid Tumors
8 March 2023
Adaptimmune and TCR2 Collaborate to Develop Cell Therapies for Solid Tumors
Adaptimmune Theraputics and TCR2 Theraputics
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry

Image

Oxford Biomedica Acquires ABL Europe from Institut Mérieux

Image

Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome